Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters.

Por Gifawesen, C, Farrell, J P
Publicado em 1989

Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.

Por Nabors, G S, Farrell, J P
Publicado em 1994

Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.

Por Nabors, G S, Farrell, J P
Publicado em 1994

Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production.

Por Li, J, Sutterwala, S, Farrell, J P
Publicado em 1997

Leishmaniasis in beige mice.

Por Kirkpatrick, C E, Farrell, J P
Publicado em 1982

In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis.

Por Li, J, Scott, P, Farrell, J P
Publicado em 1996

Cellular and humoral immune responses of jirds resistant to Dipetalonema viteae infection.

Por Abraham, D, Weiner, D J, Farrell, J P
Publicado em 1986

Protective immune responses of the jird to larval Dipetalonema viteae.

Por Abraham, D, Weiner, D J, Farrell, J P
Publicado em 1986

Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam.

Por Nabors, G S, Afonso, L C, Farrell, J P, Scott, P
Publicado em 1995